Cerebral hemodynamics and investigations of cerebral blood flow regulation

Nuclear Medicine Review

Volumn 10, Issue 1, 2007, Pages 29-42

  Rudziński, Wojciech ^a   Swiat, Maciej ^b   Tomaszewski, Maciej ^a   Krejza, Jaroslaw ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Autoregulation; Brain; Cerebral circulation; Cerebrovascular reactivity; Hemodynamics

Indexed keywords

GLUCOSE;

BIOLOGICAL MODEL; BLOOD FLOW; BLOOD PRESSURE; BRAIN; BRAIN CIRCULATION; BRAIN ISCHEMIA; BREATHING; CARDIOVASCULAR FUNCTION; COMPUTER ASSISTED TOMOGRAPHY; HOMEOSTASIS; HUMAN; INTRACRANIAL HYPERTENSION; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK FACTOR; VASCULAR RESISTANCE;

BLOOD PRESSURE; BRAIN; BRAIN ISCHEMIA; CARDIOVASCULAR PHYSIOLOGY; CEREBROVASCULAR CIRCULATION; GLUCOSE; HOMEOSTASIS; HUMANS; INTRACRANIAL HYPERTENSION; MAGNETIC RESONANCE IMAGING; MODELS, CARDIOVASCULAR; OXYGEN CONSUMPTION; POSITRON-EMISSION TOMOGRAPHY; REGIONAL BLOOD FLOW; RESPIRATION; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR RESISTANCE;

EID: 34548582081     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (154)

1. Ito H, Kanno I, Kato C et al. Database of normal human cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen measured by positron emission tomography with 15O-labelled carbon dioxide or water, carbon monoxide and oxygen: a multicentre study in Japan. Eur J Nucl Med Mol Imaging 2004; 31: 635-643. (Pubitemid 38647901)
2. Helenius J, Perkio J, Soinne L et al. Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging. Acta Radiol 2003; 44: 538-546.
3. Chih CP, Roberts Jr EL. Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis. J Cereb Blood Flow Metab 2003; 23: 1263-1281. (Pubitemid 37409789)
4. Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2003; 29: 435-450. (Pubitemid 37352643)
5. McDonald DA. Arterial impedance. In: McDonald DA, editor. Blood flow in arteries. Williams & Willkins Co, Baltimore 1977: 351-389.
6. McDonald DA. The numerical analysis of cirulatory wave-forms. In: McDonald DA, editor. Blood flow in arteries. Williams&Wilkins Co, Baltimore 1974: 146-173.
7. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959; 39: 183-238.
8. Strandgaard S, Olesen J, Skinhoj E, LASSEN NA. Autoregulation of brain circulation in severe arterial hypertension. Br Med J 1973; 1: 507-510.
9. Waldemar G, Schmidt JF, Andersen AR, Vorstrup S, Ibsen H, Paulson OB. Angiotensin converting enzyme inhibition and cerebral blood flow autoregulation in normotensive and hypertensive man. J Hypertens 1989; 7: 229-235. (Pubitemid 19093897)
10. Wallis SJ, Firth J, Dunn WR. Pressure-induced myogenic responses in human isolated cerebral resistance arteries. Stroke 1996; 27: 2287-2290.
11. Garcia-Roldan JL, Bevan JA. Flow-induced constriction and dilation of cerebral resistance arteries. Circ Res 1990; 66: 1445-1448. (Pubitemid 20147761)
12. Thorin-Trescases N, Bevan JA. High levels of myogenic tone antagonize the dilator response to flow of small rabbit cerebral arteries. Stroke 1998; 29: 1194-1200.
13. McDonald DA. Blood flow in arteries. Williams & Willkins Co, Baltimore 1977.
14. Slish DF, Welsh DG, Brayden JE. Diacylglycerol and protein kinase C activate cation channels involved in myogenic tone. Am J Physiol Heart Circ Physiol 2002; 283: H2196-H2201. (Pubitemid 35345919)
15. Kitamura K, Xiong Z, Teramoto N, Kuriyama H. Roles of inositol trisphosphate and protein kinase C in the spontaneous outward current modulated by calcium release in rabbit portal vein. Pflugers Arch 1992; 421: 539-551.
16. McCarron JG, Crichton CA, Langton PD, MacKenzie A, Smith GL. Myogenic contraction by modulation of voltage-dependent calcium currents in isolated rat cerebral arteries. J Physiol 1997; 498 (Part 2): 371-379. (Pubitemid 27073382)
17. Ngai AC, Winn HR. Modulation of cerebral arteriolar diameter by intraluminal flow and pressure. Circ Res 1995; 77: 832-840.
18. Faraci FM. Role of nitric oxide in regulation of basilar artery tone in vivo. Am J Physiol 1990; 259: H1216-H1221. (Pubitemid 20352324)
19. Lee JE, Kwak J, Suh CK, Shin JH. Dual effects of nitric oxide on the large conductance calcium-activated potassium channels of rat brain. J Biochem Mol Biol 2006; 39: 91-96. (Pubitemid 43232737)
20. Miyahara K, Kawamoto T, Sase K et al. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur J Biochem 1994; 223: 719-726. (Pubitemid 24263152)
21. Kontos HA, Raper AJ, Patterson JL. Analysis of vasoactivity of local pH, PCO2 and bicarbonate on pial vessels. Stroke 1977; 8: 358-360.
22. Horiuchi T, Dietrich HH, Hongo K, Goto T, Dacey RG, Jr. Role of endothelial nitric oxide and smooth muscle potassium channels in cerebral arteriolar dilation in response to acidosis. Stroke 2002; 33: 844-849.
23. Kovecs K, Komjati K, Marton T, Skopal J, Sandor P, Nagy Z. Hypercapnia stimulates prostaglandin E(2) but not prostaglandin I(2) release in endothelial cells cultured from microvessels of human fetal brain. Brain Res Bull 2001; 54:387-390.
24. Lindauer U, Vogt J, Schuh-Hofer S, Dreier JP, Dirnagl U. Cerebrovascular vasodilation to extraluminal acidosis occurs via combined activation of ATP-sensitive and Ca2+-activated potassium channels. J Cereb Blood Flow Metab 2003; 23: 1227-1238. (Pubitemid 37229526)
25. Toda N, Hatano Y, Mori K. Mechanisms underlying response to hypercapnia and bicarbonate of isolated dog cerebral arteries. Am J Physiol 1989; 257: H141-H146.
26. Simpson RE, Phillis JW. Adenosine deaminase reduces hypoxic and hypercapnic dilatation of rat pial arterioles: evidence for mediation by adenosine. Brain Res 1991; 553: 305-308.
27. Fredricks KT, Liu Y, Rusch NJ, Lombard JH. Role of endothelium and arterial K+ channels in mediating hypoxic dilation of middle cerebral arteries. Am J Physiol 1994; 267: H580-H586.
28. +-induced local and conducted responses in cerebral penetrating arterioles. Stroke 2002; 33: 2692-2699.
29. Di Tullio MA, Tayebati SK, Amenta F. Identification of adenosine A1 and A3 receptor subtypes in rat pial and intracerebral arteries. Neurosci Lett 2004; 366: 48-52. (Pubitemid 38953146)
30. Kleppisch T, Nelson MT. Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1995; 92: 12441-12445. (Pubitemid 26014085)
31. Li G, Cheung DW. Modulation of Ca(2+)-dependent K(+) currents in mesenteric arterial smooth muscle cells by adenosine. Eur J Pharmacol 2000; 394: 35-40.
32. Bleys RL, Cowen T. Innervation of cerebral blood vessels: morphology, plasticity, age-related, and Alzheimer's disease-related neurodegeneration. Microsc Res Tech 2001; 53: 106-118. (Pubitemid 32378042)
33. Baffi J, Gorcs T, Slowik F et al. Neuropeptides in the human superior cervical ganglion. Brain Res 1992; 570: 272-278.
34. Baumbach GL, Heistad DD. Effects of sympathetic stimulation and changes in arterial pressure on segmental resistance of cerebral vessels in rabbits and cats. Circ Res 1983; 52: 527-533. (Pubitemid 13057747)
35. Goadsby PJ, Uddman R, Edvinsson L. Cerebral vasodilatation in the cat involves nitric oxide from parasympathetic nerves. Brain Res 1996; 707: 110-118.
36. Hara H, Hamill GS, Jacobowitz DM. Origin of cholinergic nerves to the rat major cerebral arteries: coexistence with vasoactive intestinal polypeptide. Brain Res Bull 1985; 14: 179-188. (Pubitemid 15124313)
37. Morita-Tsuzuki Y, Hardebo JE, Bouskela E. Inhibition of nitric oxide synthase attenuates the cerebral blood flow response to stimulation of postganglionic parasympathetic nerves in the rat. J Cereb Blood Flow Metab 1993; 13: 993-997. (Pubitemid 23312648)
38. Edvinsson L, Ekman R, Jansen I, McCulloch J, Uddman R. Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab 1987; 7: 720-728. (Pubitemid 18029813)
39. Edvinsson L, Brodin E, Jansen I, Uddman R. Neurokinin A in cerebral vessels: characterization, localization and effects in vitro. Regul Pept 1988; 20: 181-197. (Pubitemid 18058203)
40. Uddman R, Goadsby PJ, Jansen I, Edvinsson L. PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow. J Cereb Blood Flow Metab 1993; 13: 291-297. (Pubitemid 23067464)
41. Edvinsson L, Jansen O, I, Kingman TA, McCulloch J, Uddman R. Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: possible involvement of CGRP. Cephalalgia 1995; 15: 373-383.
42. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002; 22: 54-61. (Pubitemid 34626025)
43. Weber JR, Angstwurm K, Bove GM et al. The trigeminal nerve and augmentation of regional cerebral blood flow during experimental bacterial meningitis. J Cereb Blood Flow Metab 1996; 16: 1319-1324. (Pubitemid 26365386)
44. Kalaria RN, Stockmeier CA, Harik SI. Brain microvessels are innervated by locus ceruleus noradrenergic neurons. Neurosci Lett 1989; 97: 203-208. (Pubitemid 19048936)
45. Moreno MJ, Lopez dP, Conde MV, Marco EJ. Cat cerebral arteries are functionally innervated by serotoninergic fibers from central and peripheral origins. Stroke 1995; 26: 271-275.
46. Sato A, Sato Y, Uchida S. Activation of the intracerebral cholinergic nerve fibers originating in the basal forebrain increases regional cerebral blood flow in the rat's cortex and hippocampus. Neurosci Lett 2004; 361: 90-93. (Pubitemid 38609224)
47. Cauli B, Tong XK, Rancillac A et al. Cortical GABA interneurons in neurovascular coupling: relays for subcortical vasoactive pathways. J Neurosci 2004; 24: 8940-8949. (Pubitemid 39372239)
48. Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 2004; 431: 195-199. (Pubitemid 39243473)
49. White RP, Hindley C, Bloomfield PM et al. The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: a PET study. J Cereb Blood Flow Metab 1999; 19: 673-678. (Pubitemid 30161220)
50. Belliveau JW, Kennedy DN, Jr., McKinstry RC et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 1991; 254: 716-719. (Pubitemid 21917395)
51. Zonta M, Angulo MC, Gobbo S et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 2003; 6: 43-50. (Pubitemid 36026331)
52. Bezzi P, Carmignoto G, Pasti L et al. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 1998; 391: 281-285. (Pubitemid 28099014)
53. Bhardwaj A, Northington FJ, Carhuapoma JR et al. P-450 epoxygenase and NO synthase inhibitors reduce cerebral blood flow response to N-methyl-D- aspartate. Am J Physiol Heart Circ Physiol 2000; 279: H1616-H1624.
54. Gebremedhin D, Lange AR, Lowry TF et al. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 2000; 87: 60-65. (Pubitemid 30456936)
55. Christopherson KS, Hillier BJ, Lim WA, Bredt DS. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 1999; 274: 27467-27473.
56. Pelligrino DA, Gay RL, III, Baughman VL, Wang Q. NO synthase inhibition modulates NMDA-induced changes in cerebral blood flow and EEG activity. Am J Physiol 1996; 271: H990-H995.
57. Alonso-Galicia M, Drummond HA, Reddy KK, Falck JR, Roman RJ. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension 1997; 29:320-325. (Pubitemid 27074063)
58. Sun CW, Falck JR, Okamoto H, Harder DR, Roman RJ. Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries. Am J Physiol Heart Circ Physiol 2000; 279: H339-H350. (Pubitemid 30616678)
59. Kara T, Narkiewicz K, Somers VK. Chemoreflexes - physiology and clinical implications. Acta Physiol Scand 2003; 177: 377-384. (Pubitemid 36337641)
60. Heistad DD, Marcus ML, Ehrhardt JC, Abboud FM. Effect of stimulation of carotid chemoreceptors on total and regional cerebral blood flow. Circ Res 1976; 38: 20-25.
61. Mitchell RA. Respiratory chemosensitivity in the medulla oblongata. J Physiol 1969; 202: 3P-4P.
62. Jordan J, Shannon JR, Diedrich A et al. Interaction of carbon dioxide and sympathetic nervous system activity in the regulation of cerebral perfusion in humans. Hypertension 2000; 36: 383-388.
63. Baumbach GL, Heistad DD. Effect of sympathetic stimulation and changes in arterial pressure on segmental resistance of cerebral vessels in rabitts and cats. Cir Res 1983; 52: 527-33. (Pubitemid 13057747)
64. Roatta S, Micieli G, Bosone D et al. Effect of generalised sympathetic activation by cold pressor test on cerebral haemodynamics in healthy humans. J Auton Nerv Syst 1998; 71: 159-166. (Pubitemid 28404727)
65. Heistad DD, Marcus ML. Total and regional cerebral blood flow during stimulation of carotid baroreceptors. Stroke 1976; 7: 239-243.
66. Rapela CE, Green HD, Denison AB, Jr. Baroreceptor reflexes and autorregulation of cerebral blood flow in the dog. Circ Res 1967; 21: 559-568.
67. Bondar RL, Kassam MS, Stein F, Dunphy PT, Fortney S, Riedesel ML. Simultaneous cerebrovascular and cardiovascular responses during presyncope. Stroke 1995; 26: 1794-1800.
68. Mokri B. The Monro-Kellie hypothesis - Applications in CSF volume depletion. Neurology 2001; 56: 1746-1748. (Pubitemid 32574577)
69. Miller JD. Intracranial pressure. Curr Opin Neurol Neurosurg 1989; 2: 15-20. (Pubitemid 19091798)
70. Kingman TA, Mendelow AD, Graham DI, Teasdale GM. Experimental intracerebral mass: time-related effects on local cerebral blood flow. J Neurosurg 1987; 67: 732-738. (Pubitemid 17161405)
71. Sahay KB, Mehrotra R, Sachdeva U, Banerji AK. Elastomechanical characterization of brain-tissues. Journal of Biomechanics 1992; 25: 319-26.
72. Johnston IH, Rowan JO. Raised intracranial pressure and cerebral blood flow. Venous outflow tract pressures and vascular resistances in experimental intracranial hypertension. J Neurol Neurosurg Psychiatry 1974; 37: 392-402.
73. Ikeyama A, Maeda S, Ito A, Banno K, Nagai H, Furuse M. The analysis of the intracranial pressure by the concept of the driving pressure from the vascular system. Neurochirurgia 1978; 21: 43-53. (Pubitemid 8319668)
74. Swiercz M, Mariak Z, Krejza J, Lewko J, Szydlik P. Intracranial pressure processing with artificial neural networks: prediction of ICP trends. Acta Neurochir (Wien) 2000; 142: 401-406. (Pubitemid 30209608)
75. Mariak Z, Swiercz M, Krejza J, Lewko J, Lyson T. Intracranial pressure processing with artificial neural networks: classification of signal properties. Acta Neurochir (Wien) 2000; 142: 407-411; discussion 411-412.
76. Ungerboeck K, Tenckhoff D, Heimann A, Wagner W, Kempski OS. Transcranial Doppler and cortical microcirculation at increased intracranial pressure and during the Cushing response: An experimental study on rabbits. Neurosurgery 1995; 36: 147-157.
77. Derdeyn CP, Grubb RL, Powers WJ. Cerebral hemodynamic impairment. Neurology 1999; 53: 251-259.
78. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular-disease. Ann Neurol 1991; 29: 231-240.
79. Rohl L, Ostergaard L, Simonsen CZ, Vestergaard-Poulsen P, Andersen G, Sakoh M et al. Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke 2001; 32: 1140-1146. (Pubitemid 32825798)
80. Bassingt JB. Concurrent flow model for extraction during transcapillary passage. Circ Res 1974; 35: 483-503.
81. Tiecks FP, Lam AM, Aaslid R, Newell DW. Comparison of static and dynamic cerebral autoregulation measurements. Stroke 1995; 26: 1014-1019.
82. Aaslid R, Lash SR, Bardy GH, Gild WH, Newell DW. Dynamic pressure-flow velocity relationships in the human cerebral circulation. Stroke 2003; 34: 1645-1649. (Pubitemid 36842618)
83. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990; 2: 161-192.
84. Heuser D, Astrup J, Lassen NA, Betz E. Brain carbonic-acid acidosis after acetazolamide. Acta Physiol Scand 1975; 93: 385-390.
85. Vorstrup S, Henriksen L, Paulson OB. Effect of acetazolamide on cerebral blood-flow and cerebral metabolic-rate for oxygen. J Clin Invest 1984; 74: 1634-1639. (Pubitemid 15214074)
86. Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: A positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 2001; 21: 1472-1479. (Pubitemid 33117187)
87. Sorteberg W, Lindegaard KF, Rootwelt K et al. Effect of acetazolamide on cerebral-artery blood velocity and regional cerebral bloodflow in normal subjects. Acta Neurochir 1989; 97: 139-145. (Pubitemid 19109969)
88. Grossmann WM, Koeberle B. The dose-response relationship of acetazolamide on the cerebral blood flow in normal subjects. Cerebrovasc Dis 2000; 10: 65-69. (Pubitemid 30034860)
89. Sullivan HG, Kingsbury TB, Morgan ME et al. The rCBF response to diamox in normal subjects and cerebrovascular-disease patients. J Neurosurg 1987; 67: 525-534. (Pubitemid 17145753)
90. Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Masuda K. Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral-arteries - early steal phenomenon demonstrated by [O-15]H2O positron emission tomography. Stroke 1995; 26: 1825-1829.
91. Yonas H, Pindzola RR. Physiological determination of cerebrovascular reserves and its use in clinical management. Cerebrovasc Brain Metab Rev 1994; 6: 325-340.
92. Petrella JR, Decarli C, Dagli M et al. Age-related vasodilatory response to acetazolamide challenge in healthy adults: A dynamic contrast-enhanced MR study. Am J Neurorad 1998; 19: 39-44. (Pubitemid 30430581)
93. Brian JE. Carbon dioxide and the cerebral circulation. Anesthesiology 1998; 88: 1365-1386.
94. Kanno I, Uemura K, Higano S et al. Oxygen extraction fraction at maximally vasodilated tissue in the ischemic brain estimated from the regional co2 responsiveness measured by Positron Emission Tomography. J Cereb Blood Flow Metab 1988; 8: 227-235. (Pubitemid 18079692)
95. Kazumata K, Tanaka N, Ishikawa T, Kuroda S, Houkin K, Mitsumori K. Dissociation of vasoreactivity to acetazolamide and hypercapnia - Comparative study in patients with chronic occlusive major cerebral artery disease. Stroke 1996; 27: 2052-2058. (Pubitemid 26372580)
96. Gambhir S, Inao S, Tadokoro M, Nishino M, Ito K, Ishigaki T et al. Comparison of vasodilatory effect of carbon dioxide inhalation and intravenous acetazolamide on brain vasculature using positron emission tomography. Neurol Res 1997; 19: 139-144. (Pubitemid 27190703)
97. Ringelstein EB, Vaneyck S, Mertens I. Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli - comparison of CO2 to acetazolamide. J Cereb Blood Flow Metab 1992; 12: 162-168.
98. Vorstrup S, Lassen NA. Evaluation of the cerebral vasodilatory capacity before extracranial-intracranial bypass-surgery. Acta Neurol Scand 1986; 73: 538.
99. Lam JM, Hsiang JN, Poon WS. Monitoring of autoregulation using laser Doppler flowmetry in patients with head injury. J Neurosurg 1997; 86: 438-445. (Pubitemid 27097089)
100. Bouma GJ, Muizelaar JP. Relationship between cardiac output and cerebral blood flow in patients with intact and with impaired autoregulation. J Neurosurg 1990; 73: 368-374. (Pubitemid 20260005)
101. Aaslid R, Lindegaard KF, Sorteberg W, Nornes H. Cerebral autoregulation dynamics in humans. Stroke 1989; 20: 45-52. (Pubitemid 19040212)
102. Tiecks FP, Douville C, Byrd S, Lam AM, Newell DW. Evaluation of impaired cerebral autoregulation by the Valsalva maneuver. Stroke 1996; 27: 1177-1182. (Pubitemid 26226951)
103. Brauer P, Kochs E, Werner C, Bloom M, Policare R, Pentheny S et al. Correlation of transcranial Doppler sonography mean flow velocity with cerebral blood flow in patients with intracranial pathology. J Neurosurg Anesthesiol 1998; 10: 80-85. (Pubitemid 28177879)
104. Demolis P, Dinh YRT, Giudicelli JF. Relationships between cerebral regional blood flow velocities and volumetric blood flows and their respective reactivities to acetazolamide. Stroke 1996; 27: 1835-1839. (Pubitemid 26332516)
105. Krejza J, Swiat M, Pawlak M et al. Suitability of temporal bone acoustic window: conventional TCD versus transcranial color-coded duplex sonography. J Neuroimaging 2007 (in press).
106. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. 1. Mathematical approach and statistical analysis. Magn Reson Med 1996; 36: 715-725.
107. Latchaw RE, Yonas H, Hunter GJ et al. Guidelines and recommendations for perfusion imaging in cerebral ischemia - A Scientific Statement for Healthcare Professionals by the Writing Group on Perfusion Imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke 2003; 34: 1084-1104. (Pubitemid 36402992)
108. Eastwood JD, Alexander MJ, Petrella JR, Provenzale JM. Dynamic CT perfusion imaging with acetazolamide challenge for the preprocedural evaluation of a patient with symptomatic middle cerebral artery occlusive disease. Am J Neuroradiol 2002; 23: 285-297.
109. Jain R, Hoeffner EG, Deveikis JP, Harrigan MR, Thompson BG, Mukherji SK. Carotid perfusion CT with balloon occlusion and acetazolamide challenge test: Feasibility. Radiology 2004; 231: 906-913. (Pubitemid 38668116)
110. Guckel FJ, Brix G, Schmiedek P et al. Cerebrovascular reserve capacity in patients with occlusive cerebrovascular disease: Assessment with dynamic susceptibility contrast-enhanced MR imaging and the acetazolamide stimulation test. Radiology 1996; 201: 405-412. (Pubitemid 26357635)
111. Schreiber WG, Guckel F, Stritzke P, Schmiedek P, Schwartz A, Brix G. Cerebral blood flow and cerebrovascular reserve capacity: Estimation by dynamic magnetic resonance imaging. J Cereb Blood Flow Metab 1998; 18: 1143-1156. (Pubitemid 28465362)
112. Yen YF, Field AS, Martin EM et al. Test-retest reproducibility of quantitative CBF measurements using FAIR perfusion MRI and acetazolamide challenge. Magn Reson Med 2002; 47: 921-928.
113. Kastrup A, Li TQ, Glover GH, Moseley ME. Cerebral blood flow-related signal changes during breath-holding. Am J Neurorad1999; 20: 1233-1238.
114. Detre JA, Alsop DC. Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. Eur J Radiol 1999; 30: 115-124. (Pubitemid 29281712)
115. Arbab AS, Aoki S, Toyama K et al. Quantitative measurement of regional cerebral blood flow with flow-sensitive alternating inversion recovery imaging: Comparison with [iodine123]-iodoamphetamin single photon emission CT. Am J Neurorad 2002; 23: 381-388. (Pubitemid 34241317)
116. Shiino A, Morita Y, Tsuji A et al. Estimation of cerebral perfusion reserve by blood oxygenation level-dependent imaging: Comparison with single-photon emission computed tomography. J Cereb Blood Flow Metab 2003; 23: 121-135. (Pubitemid 36015100)
117. Rostrup E, Larsson HBW, Toft PB et al. Functional MRI of CO2 induced increase in cerebral perfusion. NMR Biomed 1994; 7: 29-34.
118. Hedera P, Lai S, Lewin JS et al. Assessment of cerebral blood flow reserve using functional magnetic resonance imaging. J Magn Reson Imag 1996; 6: 718-725. (Pubitemid 126702016)
119. Bruhn H, Kleinschmidt A, Boecker H. The effect of acetazolamide on regional cerebral blood oxygenation at rest and under stimulation as assessed by MRI. J Cereb Blood Flow Metab 1994; 14: 742-748. (Pubitemid 24266526)
120. Kleinschmidt A, Steinmetz H, Sitzer M, Merboldt KD, Frahm J. Magnetic-resonance-imaging of regional cerebral blood oxygenation changes under acetazolamide in carotid occlusive disease. Stroke 1995; 26: 106-110.
121. Lythgoe DJ, Williams SCR, Cullinane M, Markus HS. Mapping of cerebrovascular reactivity using bold magnetic resonance imaging. Magn Reson Imag 1999; 17: 495-502.
122. Baron JC, Frackowiak RS, Herholz K et al. Use of PET methods for measurement of cerebral energy metabolism and hemodynamics in cerebrovascular disease. J Cereb Blood Flow Metab 1989; 9: 723-742. (Pubitemid 20006891)
123. Nemoto EM, Yonas H, Kuwabara H et al. Identification of Hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease. J Cereb Blood Flow Metab 2004; 24: 1081-1089. (Pubitemid 39332147)
124. Adams HP, Jr., Powers WJ, Grubb RL, Jr., Clarke WR, Woolson RF. Preview of a new trial of extracranial-to-intracranial arterial anastomosis: the carotid occlusion surgery study. Neurosurg Clin N Am 2001; 12: 613-661.
125. Catafau AM. Brain SPECT in clinical practice. Part 1: Perfusion. J Nucl Med 2001; 42: 259-271. (Pubitemid 32150517)
126. Hirano T, Minematsu K, Hasegawa Y, Tanaka Y, Hayashida K, Yamaguchi T. Acetazolamide reactivity on I-123 Imp single-photon emission computed- tomography in patients with major cerebral-artery occlusive disease - correlation with positron emission tomography parameters. J Cereb Blood Flow Metab 1994; 14: 763-770.
127. Imaizumi M, Kitagawa K, Hashikawa K et al. Detection of misery perfusion with split-dose I-123-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases. Stroke 2002; 33: 2217-2223. (Pubitemid 35014633)
128. Yokota C, Hasegawa Y, Minematsu K, Yamaguchi T. Effect of acetazolamide reactivity and long-term outcome in patients with major cerebral artery occlusive diseases. Stroke 1998; 29: 640-644. (Pubitemid 28145792)
129. Yonas H, Pindzola RR, Meltzer CC, Sasser H. Qualitative versus quantitative assessment of cerebrovascular reserves. Neurosurgery 1998; 42: 1005-1010.
130. Ogasawara K, Ito H, Sasoh M et al. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using (123) I-N-isopropyl-p- iodoamphetamine autoradiography with SPECT: Validation study using (H2O)-O-15 with PET. J Nucl Med 2003; 44: 520-525.
131. Ogasawara K, Okuguchi T, Sasoh M et al. Qualitative versus quantitative assessment of cerebrovascular reactivity to acetazolamide using iodine-123-N-isopropyl-p-iodoamphetamine SPECT in patients with unilateral major cerebral artery occlusive disease. AJNR Am J Neuroradiol 2003; 24: 1090-1095. (Pubitemid 36734227)
132. Lassen NA, Henriksen L, Paulson O. Regional cerebral blood-flow in stroke by Xe-133 inhalation and emission tomography. Stroke 1981; 12: 284-288. (Pubitemid 11078782)
133. Payne JK, Trivedi MH, Devous MD. Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT. J Nucl Med 1996; 37: 1735-1740. (Pubitemid 26337189)
134. Ogasawara K, Ogawa A, Terasaki K, Shimizu H, Tominaga T, Yoshimoto T. Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: Comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography. J Cereb Blood Flow Metab 2002; 22: 1142-1148. (Pubitemid 35006807)
135. Yonas H, Darby JM, Marks EC, Durham SR, Maxwell C. CBF measured by Xe-CT: approach to analysis and normal values. J Cereb Blood Flow Metab 1991; 11: 716-725.
136. Witt JP, Holl K, Heissler HE, Dietz H. Stable Xenon Ct Cbf - effects of blood-flow alterations on Cbf calculations during inhalation of 33-percent stable Xenon. AJNR Am J Neuroradiol 1991; 12: 973-975.
137. Nariai T, Suzuki R, Hirakawa K, Maehara T, Ishii K, Senda M. Vascular reserve in chronic cerebral-ischemia measured by the acetazolamide challenge test - comparison with positron emission tomography. AJNR Am J Neuroradiol 1995; 16: 563-570.
138. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion - Can acetazolamide test predict it? Stroke 2001; 32: 2110-2115.
139. Kleiser B, Widder B. Course of carotid artery occlusions with impaired cerebrovascular reactivity. Stroke 1992; 23: 171-174.
140. Vernieri F, Pasqualetti P, Passarelli F, Rossini PM, Silvestrini M. Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke 1999; 30: 593-8. (Pubitemid 29115397)
141. Settakis G, Molnar C, Kerenyi L et al. Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature. Eur J Neurol 2003; 10: 609-620. (Pubitemid 38030869)
142. Barnett HJM. Failure of extracranial intracranial arterial bypass to reduce the risk of ischemic stroke - results of an international randomized trial. NEJM 1985; 313: 1191-200.
143. Karnik R, Valentin A, Ammerer HP, Donath P, Slany J. Evaluation of vasomotor reactivity by transcranial Doppler and acetazolamide test before and after extracranial-intracranial bypass in patients with internal carotid artery occlusion. Stroke 1992; 23: 812-817.
144. Kuroda S, Kamiyama H, Abe H et al. Acetazolamide test in detecting reduced cerebral perfusion reserve and predicting long-term prognosis in patients with internal carotid-artery occlusion. Neurosurgery 1993; 32: 912-919. (Pubitemid 23157368)
145. Schmiedek P, Piepgras A, Leinsinger G, Kirsch CM, Einhaupl K. Improvement of cerebrovascular reserve capacity by EC-IC arterial bypass-surgery in patients with ICA occlusion and hemodynamic cerebral-ischemia. J Neurosurg 1994; 81: 236-244. (Pubitemid 24238003)
146. Nariai T, Suzuki R, Matsushima Y et al. Surgically induced angiogenesis to compensate for hemodynamic cerebral-ischemia. Stroke 1994; 25: 1014-1021. (Pubitemid 24130310)
147. Iwama T, Hashimoto N, Takagi Y, Tsukahara T, Hayashida K. Predictability of extracranial/intracranial bypass function: A retrospective study of patients with occlusive cerebrovascular disease. Neurosurgery 1997; 40: 53-59.
148. Sasoh M, Ogasawara K, Kuroda K et al. Effects of EC-IC bypass surgery on cognitive impairment in patients with hemodynamic cerebral ischemia. Surg Neurol 2003; 59: 455-460. (Pubitemid 36773753)
149. Widder B, Kleiser B, Krapf H. Course of cerebrovascular reactivity in patients with carotid-artery occlusions. Stroke 1994; 25: 1963-1977.
150. Henderson RD, Phan TG, Piepgras DG, Wijdicks EFM. Mechanisms of intracerebral hemorrhage after carotid endarterectomy. J Neurosurg 2001; 95: 964-979.
151. Piepgras DG, Morgan MK, Sundt TM, Yanagihara T, Mussman LM. Intracerebral hemorrhage after carotid endarterectomy. J Neurosurg 1988; 68: 532-536.
152. Reigel M, Hollier LH, Kazmier FJ, Obrien PC. Hypertension and late survival in aneurysm patients. J Am Coll Cardiol 1987; 9: A114.
153. Hosoda K, Kawaguchi T, Ishii K et al. Prediction of hyperperfusion after carotid endarterectomy by brain SPECT analysis with semiquantitative statistical mapping method. Stroke 2003; 34: 1187-1193. (Pubitemid 36547511)
154. Okudaira Y, Arai H, Sato K. Cerebral blood flow alteration by acetazolamide during carotid balloon occlusion - parameters reflecting cerebral perfusion pressure in the acetazolamide test. Stroke 1996; 27: 617-621. (Pubitemid 26114419)